Furthermore, as mitophagy is a commonly dysregulated process in PD patients and may underlie DA neuron loss, these findings introduce MIRO1 as a novel potential therapeutic target worthy of additional investigation. The gene discussed is RHOT1; the disease is Parkinson disease.